Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Steadymed Ltd Ord Sh (STDY)

4.6 0 (0%)

05-24 15:59

Open:

4.55

Pre. Close:

4.6

High:

4.65

Low:

4.55

Volume:

72,045

Market Cap:

122M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.652 - 4.68

4.68 - 4.707

Low:

4.484 - 4.517

4.517 - 4.548

Close:

4.549 - 4.598

4.598 - 4.645

Technical analysis  (as of: 2018-05-24 5:32:24 PM)

Overall:

      

Stoxline posted a SELL today, upgraded from strong sell. But this stock still is very strong for short side. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 13.86     One year: 20.56

Support:

Support1: 2.60    Support2: 2.16

Resistance:

Resistance1: 11.87    Resistance2: 17.60

Pivot:

5.51

Moving Averages:

MA(5): 7.22     MA(20): 5.19

MA(100): 3.62     MA(250): 4.26

MACD:

MACD(12,26): 0.62     Signal(12,26,9): 0.73

%K %D:

%K(14,3): 0.45     %D(3): 11.60

RSI:

RSI(14): 49.17

52-Week:

High: 7.35  Low: 2.6  Change(%): -34.8

Average Vol(K):

3-Month: 11862  10-Days 9669

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
STDY has closed above bottom band by 43.0%. Bollinger Bands are 738.6% wider than normal. The large width of the bands suggest high volatility as compared to STDY's normal range. The bands have been in this wide range for 34 bars. This is a sign that the current trend might continue.

Headline News

2018-05-15T08:03:11-04:00
SteadyMed misses by $0.18

2018-05-07T19:19:00-04:00
The Law Offices of Vincent Wong Notifies Investors of an Investigation into SteadyMed Ltd. in Connection with the Sale of the Company to United Therapeutics Corporation - STDY

2018-05-03T05:03:00-04:00
INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of SteadyMed Ltd. and Encourages Shareholders to Contact the Firm for Additional Information

2018-05-02T18:29:00-04:00
WeissLaw LLP Investigates SteadyMed Ltd.

2018-05-02T12:35:00-04:00
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Regarding Whether the Sale of SteadyMed Ltd. to United Therapeutics Corporation is Fair to Shareholders

2018-05-01T09:20:50-04:00
United Therapeutics Inks Deal To Acquire SteadyMed

2018-05-01T08:22:52-04:00
Premarket analyst action - healthcare

2018-04-30T16:30:00-04:00
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of SteadyMed Ltd. And Encourages Investors To Contact The Firm For Additional Information

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

26.58

Shares Float (M)

23.49

% Held by Insiders

11.60

% Held by Institutions

48.80

Shares Short (K)

52

Shares Short Prior Month (K)

70

Stock Financials

EPS

-0.860

EPS Est. Current Year

-1.560

EPS Est. Next Year

-0.570

EPS Est. Next Quarter

-0.190

Forward EPS

-0.460

Book Value (p.s.)

5.250

PEG Ratio

-0.14

Profit Margin

Operating Margin

-1882.35

Return on Assets (ttm)

-69.6

Return on Equity (ttm)

-121.7

Qtrly Rev. Growth

-66.2

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.042

Qtrly Earnings Growth

Operating Cash Flow (M)

-22.24

Levered Free Cash Flow (M)

-16.02

atoplab.com

Valuation

P/E

-5.35

P/E Growth Ratio

P/BV

0.88

P/S

3056699904.00

P/CF

-5.50

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.